Freyya, Salt Lake City, UT (2026)

10/22/2026

Live near DC? Want to hear the Freyya story?

On Monday evening, November 2, I’ll be pitching Freyya at the 2026 US Health Innovation Spotlight, hosted by Kaiser Permanente and Halcyon.

The evening brings together healthcare leaders and entrepreneurs working on health equity and innovation. There will be a panel discussion, live pitches from Halcyon’s 2026 US Health cohort, and a happy hour to connect afterward.

I’m proud to share the stage with Conceivable, Cove, Gisens Biotech, Jeeva AI Health Systems, Metric Health, OvaWise, Patientory, and Trans Health HQ.

📅 Monday, November 2, 2026
⏰ 5:30 to 7:30 PM ET
📍 Kaiser Permanente Center for Total Health, 700 2nd St NE, Washington, DC

Pitches start at 6:45 PM. If you’re in the area, I’d welcome the chance to meet in person.

Register here: luma.com/halcyon-1ev9

Thank you to Halcyon, Kaiser Permanente, and the program’s supporters, Merck, HPE Foundation, Deloitte, and AWS, for backing this cohort.

10/19/2026

Three days of learning, connecting, and advancing women's health in Boston! 💜
I enjoyed attending the Women's Health Innovation Summit (WHIS 2026), October 13-15, at Encore Boston Harbor.
As CEO and Co-Founder of Freyya, I particularly valued the opportunity to learn from physicians, healthcare partners, regulators, investors, and fellow entrepreneurs who are working to improve women's healthcare.
A few highlights:
🔹 Investor Reverse Pitches: One of my favorite sessions! Hearing directly from investors about their investment priorities, funding criteria, and what they look for in early-stage women's health companies was particularly valuable. Thanks to the investors who then took a meeting with me.
🔹 Clinical Innovation: Excellent discussions on emerging technologies, clinical adoption, reimbursement, and new approaches to delivering women's healthcare.
🔹 Women's Health Funding: Important conversations about the persistent funding gap, evolving investment landscape, and opportunities to build sustainable businesses in women's health.
🔹 Meaningful Connections: I especially enjoyed spending time with Dr. Lauren Dickerman, Freyya's clinical consultant and pelvic floor physical therapist. Having experienced clinicians involved in developing new medical technologies is essential.
🙏 A special thank you to Rebecca Reynolds for inviting me to the Female Founders & Funders Dinner. It was a wonderful opportunity to connect with women entrepreneurs and investors, share experiences, and discuss the challenges and opportunities of building women's health companies. Thank you also to the organizers and sponsors, including Foley Hoag and HSBC Innovation Banking.
🎉 Congratulations to Andrea Ippolito, CEO of SimpliFed, for winning the Most Innovative Partnership award at the Women’s Health Ovation Awards. Andrea and I were in the 2024 IGNITE cohort together and their progress has been tremendous.
💟 My biggest takeaway: Women's health innovation requires more than great technology. It takes clinical evidence, appropriate reimbursement, investment, and strong partnerships to bring meaningful solutions to patients.
At Freyya, we're committed to doing just that as we advance our rehabilitation technology toward commercialization.
Thank you to the WHIS organizers, especially Poppy Howard-Wall and everyone who contributed to these important conversations!

10/02/2026

Excited to attend WHIS (Women's Health Innovation Summit) 2026 in Boston, October 13-15 and connect with others working to advance women’s health innovation.

As Freyya prepares for our U.S. launch, I’m especially interested in meeting clinicians, healthcare organizations, investors, and potential partners who want to learn more about our approach to pelvic floor rehabilitation and explore opportunities to work together.

If you’ll be at WHIS, I’d love to connect. Please reach out and let’s find time to meet.

09/29/2026

🎉 Big news: Freyya has closed an oversubscribed pre-seed financing round, led by Alamo Angels.

Our product design is complete, our ERICA clinical study at the University of Utah is done, and we've engaged a contract manufacturer to prepare for production. We're now focused on our FDA submission and path to commercial launch 🚀.

🙏 Thank you to Alamo Angels, Salt Lake City Angels, and all of our investors for backing better data and better care for pelvic floor health.

Read the full announcement here: https://freyya.com/press_release/freyya-inc-closes-oversubscribed-pre-seed-financing-to-advance-fda-regulatory-milestones-and-commercialization/

Lara August
VelocityTX
Gabriele Gruss Niederauer

09/08/2026

💡 Did you know? Freyya’s technology is backed by more than 15 years of pelvic health research.

Freyya co-founders Drs. Robert Hitchcock and Stefan Niederauer have worked in pelvic floor biomechanics, intra-abdominal pressure (IAP), and sensor technology for more than 15 years. Together, their work has contributed to 20+ peer-reviewed publications advancing our understanding of pelvic floor function and the role of IAP in pelvic health.

Their experience includes development of early pelvic floor monitoring technologies and production of more than 1,400 intravaginal transducers used in the NIH-funded Motherhood and Pelvic Health (MAP) Study at the University of Utah.

That body of research helped establish the scientific foundation for Freyya.

Today, Freyya is translating more than a decade of research into an ambulatory pelvic floor monitoring and biofeedback system designed to measure pelvic floor function and IAP during real-world physical activity, when many symptoms actually occur.

This is not a new problem we recently decided to tackle. It is the next step in more than 15 years of research, engineering, and clinical collaboration.

Explore the science and our 20+ peer-reviewed publications:
https://freyya.com/publications/

Learn more at freyya.com or contact [email protected].

08/03/2026

Nine days in Chicago with Halcyon's 2026 US Health cohort recently wrapped up, and it was an energizing experience. After this kick-off in Chicago, our multi-month hybrid program includes a series of virtual sessions and a final one-week, in-person residency in Washington, DC.
Nine founders building across digital health and medtech spent the week working, learning, and pushing each other's thinking forward. I left with new friends, sharper ideas, and a much bigger network.
Why join another cohort? Two reasons. Halcyon's focus on health equity is real, not a talking point, and the access to experts in digital health is very helpful for building Freyya. Both matter directly to the work we are doing to expand access to pelvic health care for women who have been underserved for too long.
Read more in the press release: https://halcyonaccelerator.org/news/introducing-halcyons-2026-cohort-for-the-us-health-accelerator/
Grateful to be part of this cohort and looking forward to the months ahead. Follow along to see what we're building together. 🕊️

, , Karchmer, , Brinskele, , , Biotech, Kaushik, .ai, O., D., Health, Alexandre MD, , McFarlane, Inc., Hsiao MPH, Health HQ (Katie) Arnold

07/21/2026

Wearables have officially crossed the line from consumer gadgets to clinical tools.

A recent industry survey found that:
• 60% of U.S. adults now own at least one wearable or connected health device.
• 46% own a smartwatch or smart ring.
• 59% of wearable users have already discussed their device data with a healthcare provider (https://www.mddionline.com/wearable-medical-devices/wearables-have-won-over-consumers-now-they-re-coming-for-the-clinic)

The next evolution of healthcare isn't simply collecting more data. It's generating clinically meaningful data that improves patient care.

That's exactly the opportunity we saw when building Freyya.

Pelvic floor symptoms don't occur while a patient is lying on an exam table. They happen while lifting a child, exercising, walking, coughing, or simply living everyday life.

Freyya is designed to provide clinicians with objective, real-time measurements of both pelvic floor muscle activity and intra-abdominal pressure during those real-world activities. The goal isn't to replace pelvic floor physical therapy. It's to give therapists insights they've never had before, helping patients perform therapy more effectively between visits.

➡️ Consumer wearables changed how people engage with their health.

➡️ Clinical wearables have the opportunity to change outcomes.

⭐ The future of medtech is not just wearable. It's actionable.💡

06/28/2026

This week was a milestone for Freyya and one I won't soon forget. This reel is just a glimpse of the incredible Demo Day events.

It was an honor to represent Freyya at the Springboard Enterprises Women's Health Accelerator Demo Day in New York, alongside an inspiring group of founders dedicated to advancing women's health:
Jennifer Johnston (Elle, MD)
Tess Cosad (Bea Fertility)
Annie Munoz (My Village Innovations)
Raphaelle Taub (matricis.ai)
Beth Garner (Sena Therapeutics)
Loulia Kasem / Erick Garcia-Cordero (Rea Diagnostics)
Piyali Chakraborty (Ashmi Health)
Laura Jassoy (80 Beats)
Lindsay Wray (Kapha Bio)
Lara Smith (Lusome)

While Demo Day was the finale, the real value came from the journey. The thoughtful curriculum, candid feedback, investor preparation, and generosity of advisors made this one of the most impactful accelerator experiences I've had.

A heartfelt thank you to our outstanding advisory team: Georgie Kovacs, Karen Drexler, Rachel Gelman, Sarah Pettay, Ikram Guerd, Ting Shih, and Nasibeh Zanjirani Farahani. Your guidance strengthened both our strategy and our vision.

Thank you as well to the entire Springboard team, mentors, investors, and alumni for creating such an exceptional community. As a founder who has built and exited four medical device companies, I know how valuable it is to be surrounded by people who challenge, encourage, and genuinely want to see you succeed.

Women's health has been underserved for far too long, but after spending this week with so many talented founders, clinicians, investors, and industry leaders, I have never been more optimistic about the future.

Congratulations to my fellow cohort founders. It has been a privilege to be part of this remarkable journey.

06/08/2026

Pelvic floor disorders affect millions of women — yet they remain underdiscussed, undertreated, and underserved.
That's exactly why we're building Freyya.
I'm proud to announce I'll be presenting at Springboard Enterprises' 2026 Women's Health Accelerator Demo Day in New York City on June 23. Freyya's tampon-like wearable device gives women and their care teams real-time data to transform pelvic floor rehabilitation — making recovery smarter, more accessible, and centered on her outcomes.
If you're in the women's health, medtech, or investment space — I'd love to connect.
📍 Accenture Office, One Manhattan West, NYC
🗓 June 23 | 8am–12pm
🔗 Grab your spot: https://luma.com/6qd6sdke

05/25/2026

🚀 Big news from Freyya!
We were selected for the MassChallenge 2026 Healthcare & Life Sciences Traction Program — chosen from 350+ startup applications. 🎉
This is one of the world's most prestigious startup accelerator networks, and being selected is a powerful validation of our technology, our team, and the urgent need we're addressing in women's health.
We kicked off in Dallas in April, connected with incredible mentors, and just wrapped our Traction Midpoint Program in Boston. The momentum is real — and we're just getting started. 💜
Thanks for the opportunity.

Freyya

10/22/2026

10/19/2026

10/02/2026

09/29/2026

09/08/2026

08/03/2026

07/21/2026

06/28/2026

06/08/2026

05/25/2026

Address

Website

Alerts

Contact The Business

Shortcuts

Share

Category

Listing takedown request